Impact of COVID-19 on work loss in the United States- A retrospective database analysis

References

• World Health Organization. Coronavirus WHO; 2023 [Internet]. (COVID-19) dashboard [accessed 2024 Feb 26]. Available from: https://covid19.who.int
   Google Scholar
• Center for Disease Control and Prevention. Long COVID: household pulse survey; 2024 [Internet]; [updated Mar 4; accessed 2024 Mar 8]. Available from: https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm
   Google Scholar
• U.S. Bureau of Labor Statistics. Injuries, illnesses, and fatalities; 2024 [Internet]; [accessed 2024 Feb 26]. Available from: https://www.bls.gov/iif/home.htm
   Google Scholar
• Lundberg-Morris L, Leach S, Xu Y, et al. Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study. BMJ. 2023;383:e076990. doi: 10.1136/bmj-2023-076990.
   PubMedGoogle Scholar
• Malik P, Patel K, Pinto C, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-a systematic review and meta-analysis. J Med Virol. 2022;94(1):253–262. doi: 10.1002/jmv.27309.
   PubMed Web of Science ®Google Scholar
• Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417. doi: 10.1001/jamanetworkopen.2021.11417.
   PubMed Web of Science ®Google Scholar
• Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020;369:m1328. doi: 10.1136/bmj.m1328.
   PubMed Web of Science ®Google Scholar
• Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427. doi: 10.1136/bmjgh-2021-005427.
   PubMed Web of Science ®Google Scholar
• Whitaker M, Elliott J, Chadeau-Hyam M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957. doi: 10.1038/s41467-022-29521-z.
   PubMed Web of Science ®Google Scholar
• Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.
   PubMedGoogle Scholar
• Sell H, Schaible K, Gouveia-Pisano JA, et al. Economic burden of COVID-19 for employers and employees in the United States. J Med Econ. 2024;27(1):267–278. doi: 10.1080/13696998.2024.2309835.
   PubMed Web of Science ®Google Scholar
• Principi N, Autore G, Ramundo G, et al. Epidemiology of respiratory infections during the COVID-19 pandemic. Viruses. 2023;15(5):1160. doi: 10.3390/v15051160.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention [Internet]. ICD-10-CM official coding guidelines – supplement coding encounters related to COVID-19 coronavirus outbreak effective: February 20, 2020. [accessed 2024 Mar 19]. Available from: https://www.cdc.gov/nchs/data/icd/ICD-10-CM-Official-Coding-Gudance-Interim-Advice-coronavirus-feb-20-2020.pdf
   Google Scholar
• Tools Archive for Clinical Classifications Software Refined [Internet]. Healthcare cost and utilization project (HCUP). Rockville (MD): Agency for Healthcare Research and Quality; 2024 Feb 27 [accessed 2024 May 16]. Available from: www.hcup-us.ahrq.gov/toolssoftware/ccsr/ccsr_archive.jsp
   Google Scholar
• Workers Compensation Insurance Organizations [Internet]. Nature of injury code descriptions; 2023 Oct 3 [accessed 2024 Mar 19]. Available from: https://www.wcio.org/injury-description-tables
   Google Scholar
• Wage and Hour Division [Internet]. US Department of Labor. Fact sheet #28F: reasons that workers may take leave under the family and medical leave act. 2023 Mar [accessed 2024 Mar 19]. Available from: https://www.dol.gov/agencies/whd/fact-sheets/28f-fmla-qualifying-reasons
   Google Scholar
• Center for Disease Control and Prevention [Internet]. Long COVID or post-COVID conditions; 2023 [updated 2023 Jul 20; accessed 2023 Dec 24]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
   Google Scholar
• U.S. Department of Health and Human Services [Internet]. Guidance on “long COVID” as a disability under the ADA, section 504, and section 1557; 2021 Jul 26 [accessed 2024 May 16]. Available from: https://hhs.gov/civil-rights/for-providers/civil-rights-covid19/guidance-long-covid-disability/index.html#footnote10_0ac8mdc
   Google Scholar
• Nasrullah A, Gangu K, Garg I, et al. Trends in hospitalization and mortality for influenza and other respiratory viruses during the COVID-19 pandemic in the United States. Vaccines. 2023;11(2):412. doi: 10.3380/vaccines11020412.
   Web of Science ®Google Scholar
• Fine SR, Bazzi LA, Callear AP, et al. Respiratory virus circulation during the first year of the COVID-19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort. Influenza Other Respir Viruses. 2023;17(3):e13106. doi: 10.111/irv.13106.
   PubMed Web of Science ®Google Scholar
• Olsen SJ, Winn AK, Budd AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021;70(29):1013–1019. doi: 10.15585/mmwr.mm7029a1.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health & Human Services [Internet]. 2024 International Classification of Diseases, (ICD-10-CM/PCS) transition – background. Centers for Disease Control and Prevention. National Center for Health Statistics; [accessed 2024 Mar 19]. Available from: https://www.cdc.gov/nchs/icd/icd10cm_pcs_background.htm
   Google Scholar
• Center for Disease Control and Prevention [Internet]. ICD-10-CM official coding and reporting guidelines April 1, 2020 through September 30, 2020; [accessed 2024 Jan 22]. Available from: https://www.cdc.gov/nchs/data/icd/covid-19-guidelines-final.pdf
   Google Scholar
• Dinnes J, Sharma P, Berhane S, et al. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2022;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
   PubMedGoogle Scholar
• Toptan T, Eckermann L, Pfeiffer AE, et al. Evaluation of a SARS-CoV-2 rapid antigen test: potential to help reduce community spread? J Clin Virol. 2021;135:104713. doi: 10.1016/j.jcv.2020.104713.
   PubMed Web of Science ®Google Scholar
• Gómez-Ochoa SA, Franco OH, Rojas LZ, et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol. 2021;190(1):161–175. doi: 10.1093/aje/kwaa191.
   PubMed Web of Science ®Google Scholar
• İskender G, Mert D, Avşar Z, et al. COVID-19 infection among healthcare workers in an oncology hospital. J Infect Dev Ctries. 2023;17(9):1246–1254. doi: 10.3855/jidc.17404.
   PubMed Web of Science ®Google Scholar
• Li Y, Liang M, Gao L, et al. Face masks to prevent transmission of COVID-19: a systematic review and meta-analysis. Am J Infect Control. 2021;49(7):900–906. doi: 10.1016/j.ajic.2020.12.007.
   PubMed Web of Science ®Google Scholar
• Fleming Z, Brown R, Gonzales I, et al. Work from home rates have dropped to a pandemic-era low of 26% as employers make returning to the office their north star [Internet]. Fortune. 2023 Oct 16 [accessed 2024 Mar 8]. Available from: https://www.fortune.com/2023/10/16/remote-work-hybrid-return-to-office-rto/
   Google Scholar
• Stelson EA, Dash D, McCorkell L, et al. Return-to-work with long COVID: an episodic disability and Total Worker Health® analysis. Soc Sci Med. 2023;338:116336. doi: 10.1016/j.socscimed.2023.116336.
   PubMed Web of Science ®Google Scholar
• Bonner C, Ghouralal SL. Long COVID and chronic conditions in the U.S. workforce: prevalence, productivity loss, and disability. J Occup Environ Med. 2024;66(3):e80–e86. doi: 10.1097/JOM.0000000000003026.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi: 10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Toubasi AA, Al-Sayegh TN, Obaid YY, et al. Efficacy and safety of COVID-19 vaccines: a network meta-analysis. J Evid Based Med. 2022;15(3):245–262. doi: 10.1111/jebm.12492.
   PubMedGoogle Scholar
• Xu W, Ren W, Wu T, et al. Real-world safety of COVID-19 mRNA vaccines: a systematic review and meta-analysis. Vaccines. 2023;11(6):1118. doi: 10.3390/vaccines11061118.
   Web of Science ®Google Scholar
• Di Fusco M, Sun X, Moran MM, et al. Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients. J Patient Rep Outcomes. 2022;6(1):123. doi: 10.1186/s41687-022-00528-w.
   PubMedGoogle Scholar
• Di Fusco M, Cappelleri JC, Anatale-Tardiff L, et al. Impact of COVID-19 infection on health-related quality of life, work productivity and activity impairment by symptom-based long COVID status and age in the US. Healthcare. 2023;11(20):2790. doi: 10.3390/healthcare11202790.
   Web of Science ®Google Scholar
• Di Fusco M, Sun X, Anatale-Tardiff L, et al. Impact of bivalent BA.4/5 BNT162b2 COVID-19 vaccine on acute symptoms, quality of life, work productivity and activity levels among symptomatic US adults testing positive for SARS-CoV-2 at a national retail pharmacy. Vaccines. 2023;11(11):1669. doi: 10.3390/vaccines11111669.
   Web of Science ®Google Scholar